Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001650664-25-000027
Filing Date
2025-03-05
Accepted
2025-03-05 16:44:08
Documents
4
Period of Report
2025-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741211041.html 4  
1 FORM 4 wk-form4_1741211041.xml 4 4075
2 EX-24 powerofattorneyforsectio.htm EX-24 5316
3 GRAPHIC powerofattorneyforsectio001.jpg GRAPHIC 277733
4 GRAPHIC powerofattorneyforsectio002.jpg GRAPHIC 39993
  Complete submission text file 0001650664-25-000027.txt   448576
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Issuer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 138 THISTLE ROAD NORTH ANDOVER MA 08145
Business Address
Lucera Erick (Reporting) CIK: 0001697616 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37687 | Film No.: 25711948